- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03595007
The Heroes Circle Opioid Project (HCOP)
The purpose of this proposed pilot study is to extend the KKC Heroes Circle program to people with opioid use disorder (OUD) who are currently enrolled in methadone maintenance treatment (MMT) and who wish to learn these techniques to reduce their behavioral and physiological dependence on medication.
The goal is to engage these MMT patients in a complementary (non-pharmacological) therapeutic activity that may improve their self-efficacy and personal control, reduce the impact of stressors and chronic pain, drug craving, affective and physical function, and lower reliance on pharmacological interventions.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Overall, this project will take approximately 1 year to complete, and will be divided into three phases (each about three months long).
Phase 1: The investigators will identify and consent 10 patients, regardless of age, sex, or race/ethnicity, enrolled at the Tolan Park Research Clinic who endorse a desire to lower their daily methadone maintenance dose but have been unable to do so.
Each participant will complete a 12-week protocol. There will be twice weekly visits (each ≈30 min total for all procedures) by the trained adult Kids Kicking Cancer (KKC) martial artists. Prior to receiving his/her methadone dose, the martial artist and patient will meet in a private area to promote attention and focus on the intervention, and for measurement of biomarker data. At baseline and during weeks 4, 8 and 12, the investigators will obtain pre- and post-session saliva samples (collected with a Salivette held under the tongue 3 min) to measure two stress biomarkers. The investigators will also measure heart rate and blood pressure. Each participant will receive 20 minutes of individual instruction in a therapeutic approach to lower their stress and life challenges. Each visit will include certain martial arts rituals, including the KKC "Power, Peace, Purpose"™ mantra, and Breath Brake®, introduced by videotapes made by the "heroes" (children). Other components of the intervention session, e.g. movement exercises and mental imagery, will be tailored to the patient, always ensuring that any physical maneuver is safe for that individual. They will also receive audio meditations for smart phones or, if unavailable, loaded onto mp3 players to practice the meditations.
At the beginning and end of each visit by the martial artist, the participant will use Visual Analog Scales (VAS, 0-10 range) to rate his/her momentary level of "pain", "drug craving", "anxiety", "anger", and "depression"; and he/she will complete the short form of the Positive and Negative Affect Schedule. Each meeting will be supplemented by phone calls 3 times a week from the martial artist to each patient to supply support.
Data collection measurements: Beck Depression Inventory-II, State-Trait Anxiety Inventory, Perceived Stress Scale, Difficulties with Emotion Regulation Scale, Coping Orientation to Problems Experienced (Brief-COPE), Alcohol and Drug Use Self-Efficacy Scale, Distress Tolerance Scale, Breath-hold Endurance task, Brief Pain Inventory, Medical Outcomes Study Short Form, a computerized measure of attentional function, the Attentional Network Task, also known as Flanker Task.
Methadone dose (baseline and weekly) and urine drug test results (baseline and twice weekly for these study participants) will be extracted from the patient's medical record, with the assistance of an authorized staff member.
Each Phase I participant will undergo non-Virtual Reality (VR) intervention procedures during weeks 1-6, and will then undergo VR-based intervention during weeks 7-12.
Phase 2 will extend phase 1 by evaluating a second group of 10 patients who will also participate over a 12-week period. Identical procedures to Phase 1 will be used; in addition, the investigators will include whole-brain fMRI (functional magnetic resonance imaging) scanning before and after completion of the full intervention. Patients will use a Virtual Reality (VR) program that enables the patient to choose his/her obstacles and "see" that obstacle inside his/her head.
Phase 3 will enroll 10 additional patients (different participants from phases 1 and 2) who use opioids while complaining of specific chronic pain syndrome. In this phase, the same protocol will be used, including fMRI scanning. The Virtual Reality, however, will focus specifically on creating the image of the pain in wherever the pain is being reported in the body.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Michigan
-
Detroit, Michigan, United States, 48201
- Wayne State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Current diagnosis of Opioid Use Disorder
- Stable daily methadone dose for at least one month prior to enrollment
- Desire to reduce the daily methadone dose at least 20%.
Exclusion Criteria:
- Pregnant (urine test) or lactating (self-report)
- Current severe Axis I psychiatric disorder, e.g. psychosis, bipolar disorder
- Suicidal ideation/attempt during the past year
- Medical contraindications to the proposed therapeutic program, in the opinion of the clinic physician.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Phase 1
|
Individual instruction on how to lower stress and life challenges.
Patient and martial artist will work together to identify obstacles that interfere with methadone goal reduction.
Training will include learning certain martial arts rituals and breathing techniques.
Patients will receive audio meditations for smart phone devices and regular reminders to practice.
Each weekly meeting will be supplemented by 3 phone calls per week from the martial artist to support the training.
Additionally a virtual reality device will be used to help lower stress.
|
Phase 2
|
Individual instruction on how to lower stress and life challenges.
Patient and martial artist will work together to identify obstacles that interfere with methadone goal reduction.
Training will include learning certain martial arts rituals and breathing techniques.
Patients will receive audio meditations for smart phone devices and regular reminders to practice.
Each weekly meeting will be supplemented by 3 phone calls per week from the martial artist to support the training.
Additionally a virtual reality device will be used to help lower stress.
|
Phase 3
|
Individual instruction on how to lower stress and life challenges.
Patient and martial artist will work together to identify obstacles that interfere with methadone goal reduction.
Training will include learning certain martial arts rituals and breathing techniques.
Patients will receive audio meditations for smart phone devices and regular reminders to practice.
Each weekly meeting will be supplemented by 3 phone calls per week from the martial artist to support the training.
Additionally a virtual reality device will be used to help lower stress.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in methadone dose
Time Frame: Once at baseline and twice-weekly over a 12-week period.
|
Extracted from the patient's medical record
|
Once at baseline and twice-weekly over a 12-week period.
|
Drug-free urine test results (<300 ng/ml) for opioids, cocaine, benzodiazepines, and barbiturates (<300 ng/ml), and cannabinoids (<50 ng/ml).
Time Frame: Once at baseline and twice-weekly over a 12-week period.
|
Extracted from the patient's medical record
|
Once at baseline and twice-weekly over a 12-week period.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in self-report of pain, drug craving, anxiety, anger and depression
Time Frame: Beginning and end of each visit by the martial artist (pre/post effects); Once at baseline and twice-weekly over a 12-week period.
|
Measured by Visual Analog Scales (0: Not all all (Better outcome) - 10: Extremely (Worse outcome)
|
Beginning and end of each visit by the martial artist (pre/post effects); Once at baseline and twice-weekly over a 12-week period.
|
Change in self-report of the following feelings and emotions: Afraid, Ashamed, Hostile, Nervous and Upset
Time Frame: Beginning and end of each visit by the martial artist (pre/post effects); Once at baseline and twice-weekly over a 12-week period.
|
Measured by Negative Affect Schedule (1: Very slightly or not at all (Better outcome), 2: A little, 3: Moderately, 4: Quite a bit, 5: Extremely (Worse outcome)
|
Beginning and end of each visit by the martial artist (pre/post effects); Once at baseline and twice-weekly over a 12-week period.
|
Change in heart rate biomarker (beats per minute (bpm)
Time Frame: Once at baseline and once during week 4, week 8, and week 12 over the 12-week period for a total of 4 collections.
|
The investigators will obtain pre and post session heart rate measurements collected using non-invasive vital monitor
|
Once at baseline and once during week 4, week 8, and week 12 over the 12-week period for a total of 4 collections.
|
Change in blood pressure (Systolic and Diastolic mmHg) biomarker
Time Frame: Once at baseline and once during week 4, week 8, and week 12 over the 12-week period for a total of 4 collections.
|
The investigators will obtain pre and post session blood pressure measurements collected using non-invasive vital monitor
|
Once at baseline and once during week 4, week 8, and week 12 over the 12-week period for a total of 4 collections.
|
Change in saliva cortisol biomarkers
Time Frame: Once at baseline and once during week 4, week 8, and week 12 over the 12-week period for a total of 4 collections.
|
The investigators will obtain pre and post session saliva samples to measure saliva cortisol collected using Salivette held under tongue
|
Once at baseline and once during week 4, week 8, and week 12 over the 12-week period for a total of 4 collections.
|
Change in C-reactive protein biomarkers
Time Frame: Once at baseline and once during week 4, week 8, and week 12 over the 12-week period for a total of 4 collections.
|
The investigators will obtain pre and post session saliva samples to measure C-reactive protein collected using Salivette held under tongue
|
Once at baseline and once during week 4, week 8, and week 12 over the 12-week period for a total of 4 collections.
|
Percentage of patients who reduce methadone dose at least 20 percent
Time Frame: Once at baseline and twice-weekly over a 12-week period.
|
Extracted from the patient's medical record
|
Once at baseline and twice-weekly over a 12-week period.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HCOP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Opioid-use Disorder
-
Aurora Health CareUniversity of Chicago; University of California, Santa Cruz; Rogers Behavioral...RecruitingSubstance Use | Methamphetamine-dependence | Opioid Use | Opioid-use Disorder | Cocaine Use Disorder | Cocaine Use | Methamphetamine AbuseUnited States
-
Hennepin Healthcare Research InstituteNational Institute on Drug Abuse (NIDA); The Emmes Company, LLCRecruitingSubstance Use Disorder | Opioid Use Disorder, Moderate | Opioid Use Disorder, SevereUnited States
-
Hennepin Healthcare Research InstituteNational Institute on Drug Abuse (NIDA); The Emmes Company, LLCRecruitingSubstance Use Disorders | Opioid Use Disorder, Moderate | Opioid Use Disorder, SevereUnited States
-
Vanderbilt University Medical CenterCompletedOpioid Use | Opioid-use DisorderUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Albert Einstein College of MedicineNational Institute on Drug Abuse (NIDA); Pfizer; National Institutes of Health...Active, not recruitingTobacco Use Disorder | Opioid-use DisorderUnited States
-
Indiana UniversityCompletedOpioid Use | Opioid-use DisorderUnited States
-
University of ZurichCompletedOpioid Use, Unspecified With Other Opioid-induced DisorderSwitzerland
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA)CompletedOpioid-use Disorder | Cocaine Use Disorder | Healthy Controls | Marijuana Use DisorderUnited States
-
New York State Psychiatric InstituteColumbia University; Weill Medical College of Cornell University; National Institute... and other collaboratorsActive, not recruitingOpioid Use | Opioid Court Model | Medication to Treat Opioid Use DisorderUnited States
Clinical Trials on Kids Kicking Cancer program
-
Pennington Biomedical Research CenterAmerican Diabetes Association; Louisiana State University, Baton Rouge; American...CompletedFeasibility of the Camp Power Up Program on Children's Body Weight and Quality of Life (CampPowerUp)Quality of Life | Obesity, Childhood | Weight Change, BodyUnited States
-
University of AarhusTRYG FoundationUnknownSocial Anxiety DisorderDenmark
-
Baylor College of MedicineCompletedObesityUnited States
-
Johns Hopkins UniversityTruth InitiativeCompleted
-
Children's Hospital of PhiladelphiaCompletedEmotional Stress | Child Behavior Problems | Insufficient Sleep Syndrome | Inadequate Sleep HygieneUnited States
-
University of MichiganActive, not recruitingChild Mental DisorderUnited States
-
University of California, DavisCompletedAutism Spectrum DisorderUnited States
-
University of Maryland, College ParkCompletedAnxiety | Behavioral InhibitionUnited States
-
Oregon Social Learning CenterU.S. Department of EducationCompletedSchool ReadinessUnited States
-
Michigan State UniversityCompletedStress | Pediatric Obesity | Healthy Diet | Intergenerational RelationsUnited States